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Introduction
The mitogen-activated protein kinases (MAPKs), including 
extracellular signal-regulated protein kinases (ERKs), c-Jun 
NH
2
-terminal kinases (JNKs) and p38, are evolutionary con-
served families of serine/threonine kinases that control diverse 
cellular processes in response to a variety of extracellular stim-
uli (reviewed in refs. 1 and 2). MAPK activity is regulated by 
a three-module kinase cascade that include a MAPK, a MAPK 
kinase (MAP2K, MKK or MEK) and a MAPK kinase kinase 
(MAP3K, MAPKKK or MEKK).1,2 Activated MAPKs phospho-
rylate numerous downstream substrates, such as transcription 
factors, protein kinases, cytoskeletal proteins and other targets. 
The mammalian p38 MAPK family includes p38α, p38β, p38γ 
and p38δ isoforms, encoded by MAPK14, MAPK11, MAPK12 
and MAPK13 genes, respectively (reviewed in refs. 3 and 4). The 
p38 family members are activated by environmental stresses, 
inflammatory cytokines and growth factors. p38 MAPKs reg-
ulate a plethora of cellular responses including inflammation, 
proliferation, differentiation, development, cell cycle control, 
apoptosis, migration, senescence and tumorigenesis.3,4 Dual 
specificity MAP2Ks MEK3 and MEK6 are the predominant 
immediate upstream activators of p38s that phosphorylate threo-
nine-180 and tyrosine-182 residues within the activation loops 
of p38 isoforms. Additionally, MEK4- and MEK7-dependent, as 
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The p38δ mitogen-activated protein kinase (MAPK) is abun-
dantly expressed in a wide array of tissues where it is likely 
to have specific functions. This review aims to highlight recent 
new insights into the biological roles of this relatively less stud-
ied p38 isoform. We focus on function of p38δ in regulating 
of epidermal keratinocyte differentiation, apoptosis and skin 
tumor development.
well as MEK-independent activation of p38 has been reported 
(reviewed in refs. 2–4). The MAP3Ks known to participate in 
p38 activation include MEKK1-4, ASK1, TAK1, TAOs, MLK3. 
Low molecular weight GTP-binding proteins of the Rho family, 
including Rac1 and Cdc42, and p21-activated kinases (PAKs) are 
among further upstream activators of p38 signaling.2-4 The physi-
ological impact of the p38 MAPK activation is cell type- and 
stimulus-dependent, and the specific functions of the individual 
p38 isoforms under homeostatic and pathological conditions are 
not well defined. p38 isoforms are dissimilar in their pattern of 
expression, substrate specificities and sensitivity to pyridinyl imi-
dazole inhibitors.3,4 p38α and p38β isoforms are ubiquitously 
expressed and are susceptible to inhibition by pyridinyl imida-
zoles, such as SB203580. p38γ is highly expressed in skeletal mus-
cle. p38δ is abundant in many tissues, including skin, pancreas, 
testes, prostate gland, adrenal gland, small intestine, stomach, 
colon, kidney and lung.5-9 p38γ and p38δ isoforms are insensi-
tive to the pyridinyl imidazole compounds. Protein kinases MK2 
and MK3 exemplify substrates preferentially phosphorylated by 
p38α and p38β rather than p38γ and p38δ, while microtubule-
associated protein Tau appears to be a better substrate for p38γ 
and p38δ than for p38α and p38β isoforms in transfected cells.3,4 
These observations suggest highly specialized cellular functions 
for individual p38 isoforms. p38α gene ablation in mice resulted 
in early embryonic lethality due to placental and vascular abnor-
malities.10-13 p38β, p38γ, p38δ and double p38γ/p38δ knock-
out mice are viable and fertile, and exhibit no apparent health 
problems.14,15 Currently, p38α, often referred to as p38, is by far 
the best characterized isoform among p38 family members. In 
contrast, considerably less attention has been focused on p38δ. 
Here we intend to review the progress toward understanding the 
functions of the p38δ signaling in physiological and pathophysi-
ological settings, focusing, in particular, on its roles in epidermal 
keratinocytes and in epithelial carcinogenesis.
Properties of p38δ
Regulation of p38δ activity. p38δ (also called SAPK4) was 
cloned and characterized as the fourth member of the p38 
MAPK that is 61, 59 and 65% identical to p38α, p38β and p38γ, 
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remodeling.26 It is hypothesized that p38δ phosphorylates stath-
min in times of stress, which would, in conjuction with phospho-
rylation by other kinases, enhance microtubule polymerization 
to increase cell survival under stress. A microtubule-associated 
protein Tau has been found to be a good substrate for p38δ and 
p38γ in transfected COS cells.27,28 Using RNAi approach, p38δ 
has been shown to be the major in vivo kinase that phosphory-
lates endogenous Tau at threonine-50 following osmotic shock of 
neuroblastoma cells.29 Notably, phosphorylation of Tau at threo-
nine-50 is suggested to be an early event after p38δ activation. 
This phosphorylation promotes microtubule assembly and may 
play a role in the adaptation of neurons to changes in osmolarity, 
while subsequent hyperphosphorylation of Tau at additional sites 
by p38δ and/or other kinases may negatively regulate the ability 
of Tau to interact with microtubules and destabilize the micro-
tubule network.29
p38δ phosphorylates and inactivates eukaryotic elonga-
tion factor 2 kinase (eEF2K), which causes dephosphorylation 
and activation of eEF2K substrate eEF2 in response to cellular 
stress induced by anisomysin, an agent that activates all stress-
activated protein kinases, including p38δ.30 Furthermore, the 
anisomysin-induced phosphorylation of eEF2K at serine-259 in 
HEK293 cells is prevented by overexpression of a catalytically 
inactive mutant of p38δ, and is unaffected by SB203580, U0126 
or rapamycin, compounds that specifically inhibit p38α/p38β, 
MEK1 and TORC1, respectively. These data suggest that p38δ 
may mediate the inhibition of eEF2K and the resulting activation 
of eEF2, to stimulate the translation of mRNAs encoding pro-
teins whose levels are increased by stress. Fibroblast growth fac-
tor homologous factors (FHFs) are IB2-interacting proteins that 
purportedly function in facilitating the assembly of the MLK3/
MEK7/p38δ complex scaffolded by IB2 in neurons.20 FHF1 has 
been shown to serve as a p38δ substrate in transfected HEK293T 
cells treated with hydrogen peroxide.20 A transcription factor 
c-myb is phosphorylated by p38δ and, to a lesser degree, by 
p38γ, in response to anisomysin-induced stress in transfected 
HEK293 cells, leading to c-myc degradation via a proteasome-
dependent pathway.31 This regulation may have implications in 
hematopoietic cell development, inflammatory responses and 
cellular transformation. siRNA-mediated knockdown of p38δ 
enhances hypertonicity-induced transcriptional activation of 
the osmoprotective transcription factor TonEBP/OREBP, while 
overexpresson of p38δ reduces it.22 Notably, p38α is shown to 
have an opposite effect on the activity of this transcription fac-
tor. The physiological implications of the differential effects 
of p38δ and p38α isoforms on TonEBP/OREBP are presently 
being investigated.22 PKD1 has been identified as a target of p38δ 
during regulation of insulin exocytosis.32 PKD1 has been found 
to associate with ectopically expressed activated mutant form of 
p38δ (p38δF324S) in HEK293T cells and in pancreatic β cell line. 
Phosphorylation of PKD1 by p38δ negatively regulates PKD1 
activity. Moreover, PKD1 activity is enhanced in pancreatic β 
cells lacking p38δ, contributing to increased stimulated insulin 
secretion and enhanced glucose tolerance observed in p38δ-null 
mice.32 p38δ deficiency is shown to be protective against high 
fat diet-induced insulin resistance and oxidative stress-stimulated 
respectively.5-8,16 The human p38δ/MAPK13 gene is located 
on chromosome 6 and encodes a protein of 365 amino acids.7 
The expression of p38δ is regulated in different developmental 
stages in the mouse embryo, suggesting that p38δ is a develop-
mentally regulated MAPK.7 Similar to the other p38 isoforms, 
p38δ is robustly activated by inflammatory cytokines (i.e., 
TNFα, IL-1β) and environmental stresses (such as UV radia-
tion, hyperosmotic shock, oxidative stress, arsenite), and to a 
lesser degree by mitogenic stimuli. MAP2Ks reported to activate 
p38δ include MEK3, MEK6, MEK4 and MEK7.6,7,17 The activa-
tion loop (T-loop) of p38δ contributes to the specificity of activa-
tion by MEK3.18 MEK3 deficiency has been shown to abrogate 
the endogenous p38δ activation in response to TGFβ1 in murine 
glomerular mesangial cells, suggesting a critical role for MEK3 as 
an upstream activator of p38δ in this system.19 Of note, p38δ is 
activated in a glomerulonephritis disease model in rat, suggesting 
a possible involvement in the pathogenesis of this disease.6 The 
MLK3/MEK7/p38δ signaling module scaffolded by an adaptor 
protein islet brain-2 (IB2) has been described in cultured neuronal 
cells.20 Future studies using MAP2K and MAP3K gene knockout 
and RNAi-mediated knockdown approaches will define the spe-
cific contributions of individual upstream kinases in regulation 
of p38δ activity in response to a given stimulus.
Intrinsically active mutants of all p38 isoforms have been 
recently developed and demonstrated to maintain substrate 
specificity and sensitivity to inhibitors of the parental native 
p38s.21 Active mutants of p38, including p38δ mutant generated 
by substituting phenylalanine-324 with serine (F324S), acquire 
strong autophosphorylation capabilities that may emulate a natu-
ral mechanism of p38 activation. Autophosphorylation activity 
results from conformational changes conferred by activating 
mutations that are located in the L16 loop region of each iso-
form. Notably, the L16 loop of p38δ is purported to undergo 
changes via regulatory mechanisms other than phosphorylation, 
for instance, through interaction with other proteins.21
A dual-specificity phosphatase MAPK phosphatase 1 (MKP-1, 
also known as DUSP1) has been implicated in downregulation 
of hypertonicity-induced activation of both p38δ and p38α in 
HEK293FT cell line.22 In contrast, MKP-1 fails to bind to and 
inactivate p38δ in NIH3T3 cell line, and, similar to MKP-5 
(also known as DUSP10) and MKP-7 (also known as DUSP16), 
preferentially acts on p38α and p38β isoforms in this setting.23 
The involvement of protein serine/threonine phosphatases PP1 
and PP2A in downregulation of endogenous p38δ activity is sug-
gested by finding that PP1/PP2A inhibitor okadaic acid (OA) 
markedly increases p38δ activity in human epidermal kerati-
nocytes.9,24 Interestingly, the endogenous p38δ is found in a 
monophosphorylated, tyrosine-182-phosphorylated, form in 
macrophages after LPS treatment.25 Upon treatment with LPS 
and calyculin A, another inhibitor of PP1 and PP2A, p38δ activ-
ity is increased 25-fold versus LPS alone-treated cells, suggesting 
that threonine-180 may be efficiently dephosphorylated by the 
calyculin A-sensitive phosphatase(s) in this system.
p38δ substrates. Stathmin, a regulator of microtubule dynam-
ics, has been identified as p38δ substrate both in vitro and in trans-
fected cells, suggesting a potential role for p38δ in cytoskeletal 
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offered initial insights regarding the role of p38δ in epidermis 
(reviewed in ref. 40).
A robust p38δ expression is detected in developing mouse 
epidermis,7 as well as in neonatal and adult mouse and human 
epidermis,9,41 suggesting a physiological function for p38δ in epi-
dermal tissue. p38δ is expressed in both proliferating and non-
proliferating epidermal layers.9,41 Notably, p38α and p38δ are the 
predominant p38 MAPK isoforms expressed in normal keratino-
cytes, while p38β is detected at lower levels, and p38γ is virtually 
undetectable.42,43 We found that p38δ is the major p38 isoform 
activated in cultured normal human epidermal keratinocytes by 
treatment with various differentiation-inducing agents, includ-
ing 12-O-tetradecanoylphorbol-13-acetate (TPA), calcium, OA 
and green tea polyphenol.9,44 Treatment of cultured keratino-
cytes with these and other differentiation-promoting agents is 
known to induce morphological and biochemical changes, which 
resemble those taking place during epidermal differentiation in 
vivo, such as growth arrest and expression of terminal differen-
tiation markers, including involucrin expression. Cell culture 
and transgenic mouse studies show that the human involucrin 
(hINV) gene upstream regulatory region, containing functional 
activator protein 1 (AP1), CCAAT enhancer binding protein (C/
EBP), and Sp1 transcription factor binding sites, is essential for 
differentiation-appropriate hINV gene expression both in vitro 
and in vivo (reviewed in ref. 39). We have shown that differ-
entiating agent-mediated endogenous p38δ activation correlates 
with increased levels of hINV promoter activity, and endogenous 
hINV mRNA and protein expression, as well as increased pro-
tein levels and enhanced binding of AP1 and C/EBP factors to 
the hINV promoter, in cultured human keratinocytes undergo-
ing differentiation.9,44,45 These responses are maintained in the 
presence of SB203580, indicating the lack of involvement of the 
inhibitor-sensitive p38α and/or p38β isoforms. On the other 
hand, the differentiation-dependent increase in hINV promoter 
activity is inhibited by a dominant-negative mutant of p38α, 
which is expected to block activation of all p38 isoforms as it 
binds to shared direct upstream p38 activators MEK3 and MEK6. 
Moreover, the endogenous hINV protein levels are increased 
in keratinocytes overexpressing p38δ, and further increased in 
cells co-expressing both p38δ and PKCη, a differentiation-pro-
moting isoform that activates p38δ signaling in keratinocytes.45 
Altogether, these data suggest a role for p38δ isoform in acti-
vation of differentiation-dependent involucrin gene expression. 
However, the induction of involucrin expression by treatment 
with cholesterol-depleting agents involves p38α,46 and constitu-
tively active MEK6 or MEK7, when overexpressed in keratino-
cytes, increase involucrin via a mechanism that involves p38α,42,47 
suggesting that the engagement of a specific p38 isoform may be 
stimulus-dependent. Interestingly, a genomic analysis has shown 
that MAPK13 (a gene that encodes p38δ protein) and involu-
crin are among genes commonly upregulated both in psoriasis, a 
benign inflammatory condition characterized by increased pro-
liferation and differentiation, and in well-differentiated locally 
invasive cutaneous squamous cell carcinomas (SCC).48 Moreover, 
many additional genes encoding proteins involved in epidermal 
differentiation are upregulated in both conditions, including 
pancreatic β cell failure. These findings suggest a pivotal role for 
p38δ-PKD1 signaling module in regulation of pancreatic β cell 
function in diabetic conditions.32
The Role of p38δ in Regulation of Keratinocyte  
Function
The function of p38δ in keratinocyte differentiation. Epidermis, 
the outermost layer of the skin, is a stratified squamous epithelium 
that possesses a remarkable regenerating capacity and provides 
a protective barrier against environmental assaults, dehydration 
and loss of nutrients. To accomplish this critical life-sustaining 
function, keratinocytes, the major cell type of the epidermis, 
undergo a tightly regulated terminal differentiation program, 
also known as cornification (reviewed in refs. 33–38). During 
this process, mitotically active keratinocytes of the innermost 
basal layer withdraw from the cell cycle, detach from the underly-
ing basement membrane, and progressively differentiate to form 
spinous, granular and cornified epidermal layers, as they ascend 
toward the skin surface to ultimately develop into squames, dead 
flattened anucleated cornified cells.33,34 These terminally dif-
ferentiated squamous cells are composed of keratin microfibrils 
surrounded by highly crosslinked insoluble proteinaceous struc-
tures referred to as cornified envelopes, which replace the plasma 
membranes of differentiating keratinocytes. Specialized lipids 
are extruded into the intercellular space between squames and 
become covalently attached to the proteins of the cornified enve-
lope. Together, the cornified envelope and extracellular lipids are 
essential for effective physical and water barrier function in the 
skin.35 Squamous cells are eventually sloughed off the skin surface 
and are replaced by differentiating cells from the layers below. In 
healthy epidermis, normal epidermal homeostasis is maintained 
by a precisely controlled balance of proliferation, differentiation 
and death.33,34,36,37 Malfunctions in control of this balance lead to 
a compromised epidermal barrier function and result in develop-
ment of dermatological diseases, including skin cancer, psoriasis, 
disorders of keratinization and anomalous wound healing. The 
molecular mechanisms underlying epidermal growth and dif-
ferentiation control remain incompletely understood. A number 
of signaling pathways implicated in regulation of keratinocyte 
differentiation and skin barrier function has been identified in 
recent years (reviewed in refs. 33, 34, 36 and 37), including 
MAPK/SAPK cascades.
We used involucrin gene as a model to study the signaling 
mechanisms that govern epidermal gene expression during kera-
tinocyte differentiation.38-40 Involucrin is a component of the 
cornified envelope that is crosslinked to various other structural 
proteins during early stages in the envelope assembly, and pro-
vides a scaffold to which other envelope precursors are subse-
quently crosslinked.35,38,39 Involucrin is a marker of keratinocyte 
terminal differentiation that is expressed in the spinous and the 
granular, but not in the basal, epidermal layers. The investigation 
of involucrin gene regulation has revealed important mechanisms 
whereby intracellular signaling pathways and the downstream 
transcription factors regulate differentiation-dependent epider-
mal gene expression (reviewed in ref. 39), and, in particular, has 
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further ruling out the role for p38α and/or p38β isoforms in this 
process.52
PKCδ, a member of the novel PKC subfamily, has been 
implicated in regulating both the differentiation and the apop-
tosis processes in epidermal keratinocytes.24,45,54-59 We found that 
PKCδ potently activates both ectopically expressed and endog-
enous p38δ in keratinocytes.45 PKCη and PKCε are additional 
members of the novel PKC subfamily that are expressed in kera-
tinocytes.59 Paradoxically, while PKCη is also a potent activa-
tor of p38δ (a regulation associated with increased involucrin 
expression), coupling of PKCη and p38δ fails to cause apoptosis 
in this cell culture model.45,52 This is consistent with a reported 
role for PKCη as a negative regulator of UVB-induced apoptosis 
in normal human keratinocytes.60 In contrast, despite the fact 
that PKCε has been implicated in promoting cell survival and 
tumorigenesis,61 PKCε promotes apoptosis when coupled to p38δ 
in our cell culture model.52 Additional studies are needed to eluci-





), a mediator of oxidative stress-in-
duced cell death and a known inducer of keratinocyte apoptosis, 
produces similar apoptotic morphological changes, and promotes 
the endogenous PKCδ and p38δ activation, when added exog-
enously to cultured keratinocytes.52 The function of p38δ in 
promoting oxidative stress-mediated apoptosis in vivo has been 
substantiated by finding that p38δ deficient mice exhibited 5-fold 
lower rates of pancreatic β cell apoptosis in response to treatment 
with apoptosis-inducing agent streptozotocin.32
Interestingly, keratinocytes undergoing apoptosis in response 




 or OA exposure, or co-expres-
sion of PKCδ/p38δ, consistently display concurrent p38δ activa-
tion and ERK1/2 inactivation.9,24,52 We found that reduction in 
ERK1/2 activity is essential for apoptosis, since forced ERK1/2 
activation, by means of expressing constitutively active form of 
MAP3K Raf1, a specific upstream activator of ERK1/2, inhibits 
PKCδ/p38δ-induced apoptosis.52 These data suggest that a bal-
ance between prosurvival ERK1/2 signaling and proapoptotic/
prodifferentiation stress-activated protein kinase p38δ signaling 
is a crucial determinant of cell fate decisions. We studied the 
mechanisms of coordinated and inverse regulation of p38δ acti-
vation and ERK1/2 inactivation in keratinocytes. Our studies 
reveal two important aspects of this regulation: the formation of 
p38δ-ERK1/2 complex that is constitutively present in stimu-
lated and nonstimulated keratinocytes, and translocation of the 
complex from the cytoplasm into the nucleus upon stimulation 
with PKCδ.9,52 This PKCδ-stimulated nuclear co-localization of 
p38δ-ERK1/2 complex is sustained up to 48 hours after initia-
tion of treatment, and is associated with maintenance of p38δ 
activity and inactivation of ERK1/2. The latter may be carried 
out by resident nuclear phosphatases that become activated in 
response to nuclear accumulation of ERK1/2, as previously 
reported.62 Moreover, the interaction of p38δ and ERK1/2 may 
result in conformational changes in ERK1/2 that facilitate their 
interactions with phosphatases. Additionally, activated p38δ may 
act to retain unphosphorylated ERK1/2 in the nucleus, thus 
preventing ERK1/2 re-localization into the cytoplasm where 
the upstream ERK1/2 activator, MEK1, resides. Activated p38δ 
keratinocyte transglutaminase, desmoglein 3, S100 proteins and 
small proline-rich proteins. On the other hand, MAPK14 (a gene 
that encodes p38α protein) is detected to be significantly upregu-
lated in SCC only.48 Notably, invasion-associated matrix metal-
loproteinases (MMPs) 1 and 13 are also highly upregulated in 
SCC only.48 In addition, MMP1 and MMP13 expression levels 
are reduced by up to 90% by SB203580 in head and neck SCC 
(HNSCC) cell lines, suggesting a key role for SB203580-sensitive 
p38α in regulation of these enzymes (p38β expression in HNSCC 
cells is minimal).43 Of note, increased kinase activities of p38α, 
p38β and p38δ isoforms are detected in lesional compared with 
nonlesional psoriatic skin.49 Altogether, these data support the 
notion that p38 isoform-specific signaling may play distinct roles 
in regulation of epidermal homeostasis and may differentially 
contribute to the pathogenesis of various cutaneous pathologies, 
possibly via responding to different stimuli, as well as by target-
ing distinct sets of substrates.
p38δ has been implicated in regulation of differentiation in 
other cell systems, including primary human erythroid cells,50 
intestinal epithelial cells51 and the myeloid lineage cells.25 Thus, 
p38δ is expressed and active only during the terminal phase of 
erythroid differentiation.50 Additionally, p38δ mRNA and pro-
tein expression are strikingly induced during blood monocyte 
differentiation into macrophages.25 p38δ is expressed exclusively 
in differentiated enterocytes, where it appears to be required for 
execution of enterocyte anoikis.51
The function of p38δ in keratinocyte apoptosis. Our stud-
ies also show that p38δ has a role in regulation of keratinocyte 
apoptosis.24,52 This dual role for p38δ in regulation of both epi-
dermal terminal differentiation and apoptosis may not be surpris-
ing, considering that both processes are known to share some 
common regulatory pathways.53 Our studies show that OA, a 
potent inhibitor of serine/threonine protein phosphatases PP1 
and PP2A, induces both differentiation- and apoptosis-associated 
responses in keratinocytes. On the one hand, OA increases the 
expression of involucrin, a marker of keratinocyte differentiation,9 
while, on the other hand, it causes a disruption of mitochondrial 
membrane potential, and caspase-dependent apoptosis.24 These 
responses occur simultaneously in cultured keratinocytes, and 
are associated with a selective, potent and sustained activation 
of p38δ. What is more, p38α and p38β do not appear to con-
tribute to any of these responses as they occur in an SB203580-
independent manner.9,24 In addition, overexpression of p38δ 
enhances OA-induced apoptosis.24 These data indicate that p38δ 
is a mediator of OA-stimulated apoptotic cell death in keratino-
cytes. Moreover, a co-expression of p38δ together with either an 
activated form of its direct upstream activator MEK6, or its dis-
tal upstream activator PKCδ, causes apoptosis-like morphologi-
cal changes in the absence of any additional external stimulus.52 
These changes are similar to those elicited by OA exposure, and 
are associated with loss of the mitochondrial membrane poten-
tial, cytochrome c release, and killer caspase activation, the typi-
cal features of apoptotic cell death. This death response is specific 
for the combination of PKCδ and p38δ, and does not occur when 
PKCδ is replaced with PKCα, or p38δ with p38α. In addition, 
treatment of cells with SB203580 does not inhibit this response, 
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mice. Decreased skin carcinogenesis in p38δ knockout mice 
correlated with reduced epidermal proliferation during tumor 
promotion with TPA. Interestingly, a major cancer promoting 
cascade, ERK1/2-AP1 signaling pathway, showed reduced acti-
vation in TPA-treated p38δ-deficient epidermis. In this regard, 
it is noteworthy that deletion of ERK1 has been shown to inhibit 
DMBA/TPA-induced mouse skin carcinogenesis.73 In addition, 
the epidermal-specific expression of dominant-negative AP1 
transgene led to a marked resistance to chemical skin carcinogen-
esis.74 Furthermore, a repressed ERK1/2-AP1 signaling correlated 
with reduced DMBA/TPA-stimulated skin tumor development 
in JNK2 knockout mice,75 while increased ERK1/2-AP1 signal-
ing was associated with enhanced susceptibility to chemical skin 
carcinogenesis in JNK1 knockout mice.76 These findings suggest 
that a reduced proliferative response during tumor promotion 
may limit intensive tumor growth and thus account for a marked 
protection against chemical skin carcinogenesis commonly 
observed in these mouse models.
We also found that p38δ-deficient mice exhibited markedly 
reduced levels of activated signal transducer and activator of 
transcription 3 (Stat3) oncogenic transcription factor in DMBA/
TPA-induced papillomas, in comparison with tumors derived 
from their wild-type counterparts.41 This indicates that Stat3 is 
a downstream target of p38δ-stimulated signaling in skin tumor 
development. Studies using skin-specific gain and loss of func-
tion Stat3 transgenic mouse models have shown that Stat3 has 
critical roles in both chemically and UVB-induced skin carcino-
genesis.77 Stat3 is required for the survival of keratinocyte stem 
cells during tumor initiation.78 In addition, Stat3 drives epithelial 
proliferation necessary for clonal expansion of initiated cells.78 
Finally, Stat3 is known to play a role in malignant conversion by 
regulating a number of genes involved in angiogenesis and inva-
sion.79 Our data argue that p38δ regulates Stat3 activation dur-
ing epithelial carcinogenesis, suggesting that p38δ promotes skin 
tumor development at least in part by regulating Stat3 signaling 
pathway. The molecular mechanisms whereby this regulation is 
executed remain to be elucidated.
p38δ knockout mice also displayed a markedly reduced sus-
ceptibility to lung tumorigenesis induced by oncogenic muta-
tion of K-ras gene, including significantly decreased number 
of tumors, average tumor volume and total tumor volume per 
lung, compared with their wild type counterparts.41 In contrast, 
p38α deletion resulted in hyperproliferation of lung epithelium, 
and sensitized p38α-deficient mice to K-ras-induced lung tumor 
development.80 These data suggest that p38δ and p38α isoforms 
may have opposing functions in regulating oncogenic Ras-driven 
lung carcinogenesis. However, both p38α and p38δ genes are 
upregulated in human cutaneous SCCs,48 and kinase activity of 
both isoforms is increased in HNSCCs.43 Moreover, both p38α 
and p38δ are implicated in regulation of invasion and prolifera-
tion of HNSCC cells.43 Therefore, although the function for 
p38α as a tumor suppressor in vivo has been demonstrated by 
a plethora of studies using genetically engineered mouse mod-
els (reviewed in refs. 81–84), a notion that p38α signaling may 
function to promote skin tumorigenesis needs to be explored in 
future investigations.
may contribute to proapoptotic phenotype by stimulating apop-
tosis-related transcriptional changes the specific nature of which 
remains to be elucidated. Notably, a complex formation between 
p38α splice variant, Mxi2 and ERK1/2 has been recently 
reported.63,64 Mxi2 constitutively binds to ERK1/2 and promotes 
stimulus-independent ERK1/2 nuclear import. Mxi2 promotes 
nuclear accumulation of both phosphorylated and unphosphory-
lated forms of ERK1/2. The biological rationale underlying the 
Mxi2 functions in nuclear shuttling of ERK1/2 remains to be 
established. Mxi2 overexpression in certain renal tumors is asso-
ciated with ERK1/2 redistribution which may contribute to dis-
ease.64 A physical interaction between p38γ isoform and ERK1/2 
in K-Ras-transformed intestinal epithelial cells has been recently 
reported.65 It is suggested that unphosphorylated p38γ may func-
tion to promote K-Ras transformation through an increased 
complex formation with ERK1/2 proteins. A direct association 
between p38α and ERK1/2 has also been described that leads to 
ERK1/2 inhibition, purportedly via blocking MEK1-dependent 
ERK1/2 phosphorylation.66 Overall, these findings, demonstrat-
ing the capacities of different p38 isoforms to physically interact 
with ERK1/2 kinases and to modulate ERK1/2 activity and/or 
subcellular distribution, highlight the potential functional sig-
nificance of this regulatory mechanism in influencing cell fate 
decisions in response to stress.
The function of p38δ in skin tumor development. Increased 
expression of p38δ has been detected in human primary cutane-
ous SCCs,48 and increased activation of p38δ has been observed 
in HNSCC cells in culture as well as in HNSCC tumors in 
vivo.43 In addition, a recent study reports increased p38δ mRNA 
and protein levels in cholangiocarcinoma (CC), an aggres-
sive liver malignancy, and in liver cancer cell lines.67 p38δ has 
been reported to regulate HNSCC and CC invasion.43,67 Taken 
together, these findings suggest a potential role for p38δ in 
human malignancies.
Our recent study has suggested that p38δ is required for the 
development of skin tumors in the multistage chemical carcino-
genesis model in mouse skin.41 In this well characterized model 
(reviewed in refs. 68–72), during the initiation stage, a single 
topical treatment with a chemical mutagen 7,12-dimethylbenz(a)
anthracene (DMBA) induces activating mutations in H-ras gene. 
The population of mutated “initiated” cells undergoes clonal 
expansion after repeated applications of a tumor promoting 
agent, such as TPA, leading to development of benign tumors, 
papillomas. Some of papillomas may spontaneously progress to 
invasive SCCs. The conversion of papillomas to SCCs is asso-
ciated with progressive chromosomal abnormalities that occur 
independently of treatment with tumor promoting agents. As 
the multistage skin carcinogenesis model in mice recapitulates 
features of multistage carcinogenesis in humans, this model is 
a useful experimental tool to study the mechanisms of human 
epithelial carcinogenesis.68-72
Using the DMBA/TPA regimen, we found that p38δ knock-
out mice15 displayed a significantly reduced susceptibility to 
the multistage chemical skin caricnogenesis.41 p38δ deficiency 
resulted in a delay of tumor development and a significantly 
reduced numbers and size of tumors compared with wild-type 
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of inflammatory responses to various types of skin injury.89 For 
example, epidermal p38α was required for acute inflammatory 
responses to UVB-induced epidermal injury, whereas myeloid 
p38α exerted anti-inflammatory regulation in acute UVB- and 
TPA-induced skin responses via activation of anti-inflammatory 
gene expression.89 Future studies using conditional epithelial- 
and myeloid-cell-specific deletion of p38δ will identify cell type-
specific effects of p38δ deficiency on epithelial inflammatory 
responses and carcinogenesis, and will provide insights into the 
underlying molecular processes.
Concluding Remarks
Recent studies using p38δ deficient mice have begun to contribute 
to advancing our understanding of the in vivo roles of this enig-
matic p38 isoform. Thus, p38δ knockout mice have been dem-
onstrated to exhibit improved glucose tolerance due to enhanced 
insulin secretion from pancreatic β cells.32 Moreover, these mice 
are protected against high fat diet-mediated insulin resistance and 
oxidative stress-induced β cell apoptosis. This study suggests that 
p38δ is a potential therapeutic target for human diabetes.32 Our 
recent studies using p38δ knockout mice have revealed essential in 
vivo role of p38δ as a positive regulator of skin and lung tumori-
genesis.41 Moreover, increased expression and/or activity of p38δ 
are demonstrated in human malignancies, such as cutaneous SCC, 
HNSCC and liver malignancy CC.43,48,67 These findings suggest 
that targeting p38δ is a promising strategy for cancer therapy. Much 
remains to be learned regarding the molecular mechanisms under-
lying p38δ function(s) in regulation of epithelial tumorigenesis. 
A significant protection against epithelial carcinogenesis 
afforded by a germline p38δ deletion in mice41 may potentially 
be mediated by specific and/or redundant contributions from 
both epithelial and non-epithelial cell types. Development of 
epithelial-derived tumors is known to be stimulated by inflam-
mation, and inflammatory cells and mediators are present in the 
microenvironment of all tumors in experimental animal models 
and humans from the earliest stages of tumor development.84,85 
In addition, activated oncogenic Ras signaling induces produc-
tion of tumor-promoting inflammatory cytokines and chemok-
ines, which contributes to the formation of tumor-promoting 
microenvironment.85 Activation of p38 signaling is known to be 
important for the production of tumor-promoting inflammatory 
cytokines, such as TNFα, IL-1β and IL-6 (reviewed in refs. 3, 
4 and 84). p38α and p38δ are the predominant p38 isoforms 
expressed in immune (myeloid) cells.25 Interestingly, studies using 
conditional knockout of p38α in macrophages show that p38α 
is essential for production of some cytokines (such as TNFα and 
IL-12), but not others (such as IL-6), in response to stimulation 
with LPS.86 On the other hand, a recent report, using RNAi 
approach, suggests that p38δ may have a role in regulation of 
IL-6 biosynthesis.87 It is noteworthy that the mechanisms of con-
stitutive Stat3 activation in many tumors include, among others, 
both autocrine and paracrine production of IL-6 leading to Stat3 
phosphorylation.88 It would be of interest to investigate whether 
p38δ/IL-6/Stat3 signaling axis has a functional role in promot-
ing epithelial carcinogenesis. Remarkably, analysis of the effect of 
p38α ablation in myeloid and epidermal cells have revealed dis-
tinct cell type-specific functions of p38α signaling in regulation 
Figure 1. The involvement of p38δ in regulation of biological processes and disease conditions.
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carcinogenesis. Figure 1 summarizes our current understanding 
of the involvement of p38δ in regulation of various biological pro-
cesses and disease conditions, as discussed in this review.
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